abstract |
The present invention is in the field of the pharmaceutical industry and relates to solid pharmaceutical compositions comprising androgen receptor antagonists, such as, for example, < RTI ID = 0.0 > ezalutamide < / RTI > or ARN-509, Solid pharmaceutical compositions are useful in the treatment of prostate cancer. |